论文部分内容阅读
对73例病人的骨髓细胞进行核仁组成区相关嗜银蛋白(Ag-NOR)染色,结果表明非肿瘤性疾病与肿瘤性疾病未经治疗或治疗后缓解两组之间的差别有显著性差异(P<0.01);骨髓增生异常综合征(MDS)组与非肿瘤性疾病组之间差别有显著性差异(P<0.01);肿瘤性疾病未缓解组与肿瘤性疾病治疗缓解组之间差别有显著性差异(P<0.01),提示Ag-NOR染色对骨髓细胞良、恶性疾病具有鉴别价值。
The results of Ag-NOR staining showed that there was a significant difference between the two groups in the non-neoplastic and non-neoplastic diseases after untreated or after treatment (P <0.01). The difference between the MDS group and the non-neoplastic disease group was significant (P <0.01). The differences between the non-neoplastic group and the neoplastic disease remission group were significant There was a significant difference (P <0.01), suggesting that Ag-NOR staining of myeloid cells with benign and malignant disease has differential value.